Industry: Healthcare | Publish Date: 29-Nov-2024 | No of Pages: 239 | No. of Tables: 131 | No. of Figures: 101 | Format: PDF | Report Code : HC335
The Global External Defibrillators Market size was valued at USD 5.67 billion in 2019, and is predicted to reach USD 11.01 billion by 2030, with a CAGR of 6.1% from 2020-2030.
The global sale of External Defibrillators was 3.11 million units in 2019, which is projected to escalate by 9.50 million units by 2030, with a CAGR of 10.7%, from 2020-2030.
External defibrillators are medical devices that are used to deliver controlled dosage of electric current to the patient’s heart, in life-threatening conditions of cardiac dysrhythmias; majorly VF (Ventricular Fibrillation) and VT (non-perfusing Ventricular Tachycardia). Counter-shock given to the patient’s heart tends to depolarize a large amount of heart muscle, thereby terminating the dysrhythmia.
Different types of external defibrillators include Manual External Defibrillators, Automated External Defibrillators (AEDs), and Wearable External Defibrillators (WCD). With technological advancements, the adoption of AEDs and WCDs are gaining momentum, thereby supplementing the growth of global External Defibrillators market.
The AEDs are portable, fully automated, can analyze heart rhythms for shocks, can be operated by layperson, as well as these are fast and easy to operate. These benefits are expected to escalate the growth of External Defibrillators market in coming future.
According to data provided by the World Health Organization (WHO) in 2017, Cardiovascular Diseases (CVDs) caused about 31% of global deaths, of which 85% deaths result from heart attack and stroke. This scenario further supplements the growth of global External Defibrillators market.
Furthermore, increasing installations of Public Access Defibrillator (PAD) at various public places, along with improving healthcare infrastructures equipped with advanced amenities, further propagates the growth of global External Defibrillators market.
However, high costs, increasing number of product recalls, and lack of consumer awareness, are the limiting factors that are expected to negatively affect the growth of global External Defibrillators market.
Moreover, increasing geriatric population, growing number of approvals granted by the U.S FDA, and increasing government investments in public interest, are anticipated to boost-up the growth of global External Defibrillators market.
The global External defibrillators market share has been analyzed based on product type, end user and geography.
Based on product type, the market is segmented into Manual External Defibrillator, Automated External Defibrillator (AED), and Wearable Cardioverter Defibrillator (WCD). The Automated External Defibrillator is sub segmented into Semi-Automated External Defibrillator and Fully Automated Defibrillator. Based on end user, the market is divided into pre-hospitals, hospitals, alternate care market, public access market, and home. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
North America is estimated to account for the major market share in the global External defibrillators market throughout the forecast period, owing to the increased adoption of external defibrillators due to higher prevalence of CVDs because of sedentary lifestyles. Furthermore, adoption of advanced automated technologies, well-established healthcare infrastructures and medical laboratories are further expected to fuel the growth of external defibrillator market.
Asia Pacific is expected to show a rapidly growing External defibrillators market, owing to the increasing incidences of CVDs, improvement in the healthcare facilities, and growing awareness regarding treatment options.
The External defibrillators market is highly competitive and consists of various market players. Some of the major market players include Cardiac Science Corporation, Nihon Kohden Corporation, HeartSine Technologies LLC., Philips Healthcare, Mindray Medical International Limited, ZOLL Medical Corporation, Defibtech, LLC., GE Healthcare, Schiller Ag, and Physio-Control, Inc., among others.
The key players are employing strategies such as product launches, acquisitions, and technical collaboration, in-order to gain stronger position in the External defibrillators market. Additionally, increasing number of FDA approvals further stimulates the growth of External defibrillators market.
For instance, in August 2019, Cardiac Science Corporation, one of the major players in the global external defibrillators market, announced that it has been acquired by an Asahi Kasei Group Company named ZOLL Medical Corporation. With this acquisition ZOLL aims to provide integrated, acute, innovative, and resuscitation care for Cardiac Arrest Victims.
In December 2019, Mindray Medical International Limited, one of the major players in the global external defibrillators market, introduced its BeneHeart C Series Automated External Defibrillators. Mindray’s AEDs are intelligent, intuitive, provide high operational efficacy, and faster shock delivery. Besides, it imparts better resuscitation outcomes for Sudden Cardiac Arrest (SCA).
In June 2020, ZOLL Medical Corporation, one of the major players in the global external defibrillators market, announced that ZOLL AED 3 defibrillator has received PMA (Pre-Market Approval) by the U.S FDA for utilization by lay rescuers. The new AEDs by ZOLL, are compatible with enhanced real CPR help, integrated child rescue, and wireless connectivity. With this, ZOLL aims at providing emergency preparedness during the COVID-19 pandemic.
The External defibrillators market report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on.
The study comprises a deep dive analysis of the External defibrillators market trend including the current and future trends for depicting the prevalent investment pockets in the market.
The report provides detailed information related to key drivers, restraints, opportunities, and their impact on the External defibrillators market is provided in the report.
The report provides competitive analysis of the market players along with their market share in the global External defibrillators market.
The SWOT analysis and Porters Five Forces model is elaborated in the study of the External defibrillators market.
Value chain analysis in the External defibrillators market study provides a clear picture of the stakeholders’ roles.
Manual External Defibrillator
Automated External Defibrillator (AED)
Semi-Automated External Defibrillator
Fully Automated Defibrillator
Wearable Cardioverter Defibrillator (WCD)
Hospitals
Pre-Hospitals
Public Access Market
Alternate Care Market
Home
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
RoW
Brazil
Argentina
Egypt
Israel
South Africa
Remaining Countries
Cardiac Science Corporation
Nihon Kohden Corporation
HeartSine Technologies LLC.
Philips Healthcare
Mindray Medical International Limited
ZOLL Medical Corporation
Defibtech, Llc
GE Healthcare
Schiller Ag
Physio-Control, Inc.
REPORT SCOPE AND SEGMENTATION:
Parameters |
Details |
Analysis Period |
2019–2030 |
Base Year Considered |
2020 |
Forecast Period |
2020–2030 |
Market Size Estimation |
Billion (USD) |
Market Segmentation |
By Product Type (Manual External Defibrillator, Automated External Defibrillator (AED), Wearable Cardioverter Defibrillator (WCD) By End User (Hospitals, Prehospitals, Public Access Markets, Alternative Care Market, Home) |
Geographical Segmentation |
North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), Rest of the World (Brazil, Argentina, Egypt, Israel, South Africa, Remaining Countries) |
Companies Profiled |
Cardiac Science Corporation, Nihon Kohden Corporation, HeartSine Technologies LLC., Philips Healthcare, Mindray Medical International Limited, ZOLL Medical Corporation, Defibtech, LLC., GE Healthcare, Schiller Ag, and Physio-Control, Inc. |